31-45 of 811
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
On the Frontlines of Metastatic Breast CancerDESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Modern Approaches to Long-Term Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerModern Approaches to Long-Term Metastatic Breast Cancer Care
Genomic Profile of ER+ HER2- Metastatic Invasive Lobular Carcinoma
Project Oncology®Genomic Profile of ER+ HER2- Metastatic Invasive Lobular Carcinoma
Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
Project Oncology®Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®The Metabolic Roots of Early-Onset Colorectal Cancer
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Project Oncology®AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
- advertisement
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
Clinician's RoundtableHow COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
Project Oncology®ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
Deep Breaths: Updates from CHESTRedefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
Clinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment
Deep Breaths: Updates from CHESTClinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Project Oncology®Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
- advertisement
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Project Oncology®From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Tracking Tumor Resistance in Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerTracking Tumor Resistance in Metastatic Breast Cancer Care
Optimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
AudioAbstractsOptimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
